Cyder is at it again in his PMs. The guy is a dolt
Post# of 155211

Quote:
Quote:
i remember your endless insistence that leron would do wonders for cancer BY ITSELF. it failed breast cancer without the combo. if not for the lucky find (my god that company is clueless) on that combo data, the company would be in trouble.
It beat Trodelvy on median overall survival in the mTNBC trial. It wasn't a lucky find. They were measuring for PD-L1 in the trials.
Quote:
you still think ccr5 inhibition w leron's super high receptor occupancy does everything that every single other drug on earth does, but 10x better? why was it a failure in mash and tnbc then?
It had statistical significance in the NASH trial which is amazing given the low number of patients.

